Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.61 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.61 |
| ▸ | F2 | P00734 | 4/20 | 0.60 |
| ▸ | NPY1R | P25929 | 4/20 | 0.57 |
| ▸ | NPY2R | P49146 | 4/20 | 0.57 |
| ▸ | NPY4R | P50391 | 4/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.57 |
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4139781 | 1.00 | NMUR2 (0.61) | NMUR2NMUR1F2NPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL2034151 | 1.00 | NMUR2 (0.61) | NMUR2NMUR1F2NPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL16029740 | 1.00 | NMUR2 (0.61) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL23278082 | 0.98 | NMUR2 (0.64) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL29389211 | 0.98 | NMUR2 (0.64) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL25739 | 0.98 | NMUR2 (0.64) | NMUR2NMUR1F2NPY1RNPY2R | |
| Acetic Acid SCHEMBL2037978 | 0.97 | NMUR2 (0.63) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL28366588 | 0.97 | NMUR2 (0.65) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL30753221 | 0.96 | NMUR2 (0.61) | NMUR2NMUR1F2NPY1RNPY2R | |
| SCHEMBL23630197 | 0.96 | NMUR2 (0.62) | NMUR2NMUR1F2NPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4164674-B1 | MODULATORS OF TIGHT JUNCTION PERMEABILITY | UNIV BATH (GB) | 2025-10-22 | — | — | EP | disclosed |
| EP-3903733-B1 | FLUID EXCHANGE APPARATUS | FORSIGHT VISION4 INC (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4249059-B1 | AN APPARATUS FOR COLLECTING A SAMPLE OF FLUID FROM A RESERVOIR CHAMBER OF A THERAPEUTIC DEVICE FOR THE EYE | FORSIGHT VISION4 INC (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-3217924-B1 | EXPANDABLE DRUG DELIVERY DEVICES | FORSIGHT VISION4 INC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-12251336-B2 | Expandable drug delivery devices and methods of use | FORSIGHT VISION4, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| US-12201556-B2 | Porous structures for extended release drug delivery devices | FORSIGHT VISION4, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240139027-A1 | DIAGNOSTIC METHODS AND APPARATUS | FORSIGHT VISION4, INC. | 2024-05-02 | — | — | US | disclosed |
| CN-117836051-A | Multi-layer microfluidic system and method | 北加州大学药学院 | 2024-04-05 | — | — | CN | disclosed |
| US-11846640-B2 | Identification of anticoagulants in a sample | PENTAPHARM AG (CH) | 2023-12-19 | — | — | US | disclosed |
| US-11813196-B2 | Diagnostic methods and apparatus | FORSIGHT VISION4, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11679027-B2 | Combined drug delivery methods and apparatus | FORSIGHT VISION4, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-11642310-B2 | Posterior segment drug delivery | FORSIGHT VISION4, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20230072346-A1 | POROUS STRUCTURES FOR EXTENDED RELEASE DRUG DELIVERY DEVICES | FORSIGHT VISION4, INC. | 2023-03-09 | — | — | US | disclosed |
| CN-105744935-B | Hydrazino-pyrrolo compounds and methods for forming conjugates | 雷德伍德生物科技股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-11432959-B2 | Porous structures for extended release drug delivery devices | FORSIGHT VISION4, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| CN-114632019-A | Compositions and methods of use for treating or improving the condition and appearance of skin | 科思柔 | 2022-06-17 | — | — | CN | disclosed |
| CN-114555620-A | Novel galactoside inhibitors of galectins | 格莱克特生物技术公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114450282-A | Novel galactoside inhibitors of galectins | 格莱克特生物技术公司 | 2022-05-06 | — | — | CN | disclosed |
| US-20220087863-A1 | EXPANDABLE DRUG DELIVERY DEVICES AND METHODS OF USE | FORSIGHT VISION4, INC. | 2022-03-24 | — | — | US | disclosed |
| EP-3960134-A1 | IMPLANTABLE THERAPEUTIC DEVICE | ForSight Vision4, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |